CVE:VM Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis C$0.05 -0.01 (-9.09%) (As of 05:20 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChart Get Voyageur Pharmaceuticals alerts: Email Address About Voyageur Pharmaceuticals Stock (CVE:VM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VM alerts:Sign Up Key Stats Today's RangeC$0.05▼C$0.0550-Day RangeC$0.05▼C$0.0752-Week RangeC$0.04▼C$0.09Volume14,000 shsAverage Volume86,122 shsMarket CapitalizationC$6.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVoyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.Read More… Unlock the Secret to Easy Wins with Iron Condors (Ad)Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consistently without needing a large account or watching the market all day. Our free report, The Top 10 Stocks for Iron Condor Trades, reveals exactly how to set up winning trades with minimal downside.Download Your FREE Iron Condor Guide Now Receive VM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address VM Stock News HeadlinesVoyageur Pharmaceuticals Ltd (VM)August 10, 2024 | investing.comUpdate - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium ContrastMay 28, 2024 | finance.yahoo.comKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election Meltdown” coming this November.September 18, 2024 | Paradigm Press (Ad)Voyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonMarch 13, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd VMJanuary 3, 2024 | morningstar.comVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsDecember 21, 2023 | stockhouse.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)December 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)October 24, 2023 | theglobeandmail.comSee More Headlines VM Stock Analysis - Frequently Asked Questions How have VM shares performed this year? Voyageur Pharmaceuticals' stock was trading at C$0.08 at the beginning of 2024. Since then, VM stock has decreased by 33.3% and is now trading at C$0.05. View the best growth stocks for 2024 here. How do I buy shares of Voyageur Pharmaceuticals? Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Voyageur Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC) and EQT (EQT). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VM CUSIPN/A CIKN/A Webwww.voyageurminerals.ca Phone587-779-6166FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-1,300,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-84.77% Return on Assets-30.77% Debt Debt-to-Equity Ratio3.21 Current Ratio0.17 Quick Ratio0.84 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC$0.01 per share Price / Book5.00Miscellaneous Outstanding Shares139,470,000Free FloatN/AMarket CapC$6.97 million OptionableNot Optionable Beta0.32 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (CVE:VM) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyageur Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.